Athersys ATHX Stock
Athersys Price Chart
Athersys ATHX Financial and Trading Overview
| Athersys stock price | USD |
| Previous Close | 0.96 USD |
| Open | 0.98 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 0.93 - 0.99 USD |
| 52 Week Range | 0.5 - 10.5 USD |
| Volume | 79.41K USD |
| Avg. Volume | 145.9K USD |
| Market Cap | 19.41M USD |
| Beta (5Y Monthly) | -0.736619 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.5 USD |
ATHX Valuation Measures
| Enterprise Value | 25.39M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.24 |
| PEG Ratio (5 yr expected) | 0 |
| Price/Sales (ttm) | 8.043903 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.524 |
| Enterprise Value/EBITDA | -0.501 |
Trading Information
Athersys Stock Price History
| Beta (5Y Monthly) | -0.736619 |
| 52-Week Change | -86.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.5 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 0.91 USD |
| 200-Day Moving Average | 1.31 USD |
ATHX Share Statistics
| Avg. Volume (3 month) | 145.9K USD |
| Avg. Daily Volume (10-Days) | 82.77K USD |
| Shares Outstanding | 20.87M |
| Float | 20.59M |
| Short Ratio | 10.07 |
| % Held by Insiders | 0.64% |
| % Held by Institutions | 10.49% |
| Shares Short | 1.02M |
| Short % of Float | 4.90% |
| Short % of Shares Outstanding | 4.88% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2151.26% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -97.44% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.41M USD |
| Revenue Per Share (ttm) | 0.17 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -50685000 USD |
| Net Income Avi to Common (ttm) | -58129000 USD |
| Diluted EPS (ttm) | -4.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.12M USD |
| Total Cash Per Share (mrq) | 0.15 USD |
| Total Debt (mrq) | 8.44M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.197 |
| Book Value Per Share (mrq) | -1.681 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44748000 USD |
| Levered Free Cash Flow (ttm) | -12266750 USD |
Profile of Athersys
| Country | United States |
| State | OH |
| City | Cleveland |
| Address | 3201 Carnegie Avenue |
| ZIP | 44115-2634 |
| Phone | 216 431 9900 |
| Website | https://www.athersys.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.
Q&A For Athersys Stock
What is a current ATHX stock price?
Athersys ATHX stock price today per share is USD.
How to purchase Athersys stock?
You can buy ATHX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Athersys?
The stock symbol or ticker of Athersys is ATHX.
Which industry does the Athersys company belong to?
The Athersys industry is Biotechnology.
How many shares does Athersys have in circulation?
The max supply of Athersys shares is 0.
What is Athersys Price to Earnings Ratio (PE Ratio)?
Athersys PE Ratio is now.
What was Athersys earnings per share over the trailing 12 months (TTM)?
Athersys EPS is 0 USD over the trailing 12 months.
Which sector does the Athersys company belong to?
The Athersys sector is Healthcare.
Athersys ATHX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
| NASDAQ Composite Total Return XCMP | 22955.12 USD — |
-0.99
|
— — | 22786.65 USD — | 23082.91 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
- {{ link.label }} {{link}}